Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
26.19
+0.36 (1.39%)
At close: Aug 14, 2026, 4:00 PM EDT
25.88
-0.31 (-1.18%)
After-hours: Aug 14, 2026, 7:51 PM EDT
Arcutis Biotherapeutics Market Cap
Arcutis Biotherapeutics has a market cap or net worth of $3.29 billion as of August 14, 2026. Its market cap has increased by 75.65% in one year.
Market Cap
3.29B
Enterprise Value
3.17B
1-Year Change
75.65%
Ranking
Category
Stock Price
$26.19
ChartMarket Cap Chart
Since January 31, 2020, Arcutis Biotherapeutics's market cap has increased from $782.04M to $3.29B, an increase of 320.93%. That is a compound annual growth rate of 24.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 3.29B | -7.46% |
| Dec 31, 2025 | 3.56B | 118.17% |
| Dec 31, 2024 | 1.63B | 434.82% |
| Dec 29, 2023 | 304.85M | -66.18% |
| Dec 30, 2022 | 901.45M | -13.58% |
| Dec 31, 2021 | 1.04B | -14.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 31, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AbCellera Biologics | 3.69B |
| IDEAYA Biosciences | 3.50B |
| uniQure | 3.37B |
| MBX Biosciences | 3.30B |
| Celldex Therapeutics | 3.29B |
| Alumis | 3.28B |
| NewAmsterdam Pharma Company | 3.23B |
| Iovance Biotherapeutics | 3.16B |